In contrast to this, ALT levels failed to demonstrate any significant differentiating potential between CHC patients with normal ALT levels and healthy controls (AUC: 0.601; 95% CI: 0.479–0.714; P > 0.05) (Fig. 5b). The gene discussed is GPT; the disease is cryohydrocytosis.